Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05811325
Other study ID # REC/RCR&AHS/22/0538
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 11, 2022
Est. completion date January 30, 2023

Study information

Verified date March 2023
Source Riphah International University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

SIJ dysfunction adversely affects quality of life and causes functional impairment and disability. Although, K taping and craniosacral therapy were previously affective in treating SI joint dysfunction, the combined affects of these intervention have not been compared previously to K taping alone.


Description:

This study is a randomized controlled trial and have 30 pregnant women suffering from SIJH dysfunction. There is 2 groups and both have received treatment for 6 weeks. The data on pain is collected through VAS and the data on disability is collected through Oswestry Disability Index, and data on quality of life will be collected using SF-36. Measurements will be taken at the beginning of the study and at the end of the 4th week, at the completion of the study. Data will be analyzed using SPSS.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date January 30, 2023
Est. primary completion date December 30, 2022
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria: - age between 18-35 - pregnant females in 3rd trimester - pregnant females with SIJ dysfunction Exclusion Criteria: - high risk pregnancy - pregnant females with hypermobility syndrome - previous pelvic history

Study Design


Related Conditions & MeSH terms


Intervention

Other:
kinesiotaping without craniosacral therapy
The first treatment group will receive kinesio taping for 6 weeks atleast 4 times per week
kinesiotaping with craniosacral therapy
The second treatment group will receive kinesio taping with craniosacral therapy for 6 weeks atleast 4 times per week with each session lasting for 60 minutes

Locations

Country Name City State
Pakistan Mayo Hopital Lahore

Sponsors (1)

Lead Sponsor Collaborator
Riphah International University

Country where clinical trial is conducted

Pakistan, 

Outcome

Type Measure Description Time frame Safety issue
Primary VISUAL ANALOGUE SCALE This scale is used to assess pain. 6 WEEKS
Primary Oswestry Disability Index it is used to measure disability. 4 weeks
Secondary SF-36 Data on quality of life is measured by this scale. 4 weeks
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04559295 - Bone Marrow Concentrate (BMC) Injection in Intervertebral Discs Phase 2/Phase 3